Why We're Still Waiting on an Ebola Vaccine

March 11, 2015 3:47 PM

4 0

Why We're Still Waiting on an Ebola Vaccine

From November to January, small trials on the adenovirus and VSV Ebola vaccines in the U.S., the U.K., Switzerland, Canada, Germany, Mali, Kenya and Gabon showed that people given the shots did not develop life-threatening side effects in the weeks that followed. In January a 600-person placebo-controlled trial designed to assess the safety of the adenovirus and VSV Ebola vaccines as well as the buildup of antibodies was slated to launch in Liberia.

The team was delayed, however, because potential study participants were uneasy, said Fatorma Bolay, director of the Liberian National Institute for Biomedical Research and one of the study’s lead researchers. He decided to step up his team’s outreach in the community where they hoped to enroll part...

Read more

To category page

Loading...